who found that γδ T cells in the bone marrow (BM) from patients with AML and MM showed an increased expression of the co-inhibitory molecules PD-1, TIGIT, TIM-3, or CD39 in contrast to HIs (16). This evidence concerns the gene ENTPD1 and acute myeloid leukemia.